CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 42 filers reported holding CYTEIR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,920,916 | -79.8% | 676,379 | -81.5% | 0.14% | -80.7% |
Q2 2023 | $9,522,854 | -91.6% | 3,662,636 | -7.0% | 0.74% | -90.1% |
Q1 2023 | $112,892,832 | +1636.4% | 3,940,413 | 0.0% | 7.45% | +1734.7% |
Q4 2022 | $6,501,681 | -14.1% | 3,940,413 | 0.0% | 0.41% | +12.5% |
Q3 2022 | $7,566,000 | -47.7% | 3,940,413 | -18.6% | 0.36% | -49.4% |
Q2 2022 | $14,473,000 | -20.7% | 4,840,413 | 0.0% | 0.71% | -26.0% |
Q1 2022 | $18,248,000 | -66.8% | 4,840,413 | 0.0% | 0.96% | -63.0% |
Q4 2021 | $55,035,000 | -35.2% | 4,840,413 | 0.0% | 2.61% | -40.7% |
Q3 2021 | $84,949,000 | -18.0% | 4,840,413 | 0.0% | 4.39% | -4.4% |
Q2 2021 | $103,585,000 | – | 4,840,413 | – | 4.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 2,459,572 | $4,476,421 | 8.93% |
Novo Holdings A/S | 3,940,413 | $112,892,832 | 7.45% |
BML Capital Management, LLC | 3,146,296 | $5,726,259 | 4.95% |
Newtyn Management, LLC | 952,947 | $1,734,364 | 0.34% |
Aldebaran Capital, LLC | 151,239 | $275,255 | 0.28% |
Avidity Partners Management LP | 1,764,100 | $3,210,662 | 0.11% |
Marquette Asset Management, LLC | 67,990 | $123,742 | 0.03% |
TANG CAPITAL MANAGEMENT LLC | 100,000 | $182,000 | 0.03% |
RBF Capital, LLC | 117,295 | $213,477 | 0.02% |
CAAS CAPITAL MANAGEMENT LP | 150,406 | $273,739 | 0.02% |